Abstract
The distribution and localization of NCA and carcinoembryonic antigen CEA in cells of different types of myelogenous leukaemias (acute myelogenous leukaemia - AML; chronic granulocytic leukaemia - CGL; CGL in myeloblastic crisis - CGL-BC) was studied using the immunofluorescence test. Discontinuous density-gradient centrifugation was used to separate myeloid cells into fractions containing granulocytes in individual stages of maturation. Serum NCA and CEA levels were estimated in parallel. It was established that: (a) AML blasts without maturation (MO type) and monoblasts did not synthesize NCA; (b) individual blasts of AML with features of maturation (M1, M2 types) and some myeloblasts of CGL-BC exhibited a limited ability to express cytoplasmic NCA; (c) the number of NCA-containing cells increased in the more mature granulocyte fractions isolated on Ficoll-Hypaque density-gradients; (d) myelocytic NCA is immunologically related to NCA isolated from lung tissue and (e) CEA is undetectable in the myelocytic cell series.
Full text
PDF






Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
- Bordes M., Knobel S., Martin F. Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissues. Eur J Cancer. 1975 Nov;11(11):783–786. doi: 10.1016/0014-2964(75)90171-1. [DOI] [PubMed] [Google Scholar]
- Burtin P., Flandrin G., Fondaneche M. C. Presence of NCA (nonspecific cross-reacting antigen) in the cells of the human granulocyte series. Blood Cells. 1980;6(2):263–278. [PubMed] [Google Scholar]
- Burtin P., Quan P. C., Sabine M. C. Nonspecific cross reacting antigen as a marker for human polymorphs, macrophages and monocytes. Nature. 1975 Jun 26;255(5511):714–716. doi: 10.1038/255714a0. [DOI] [PubMed] [Google Scholar]
- Chavanel G., Frenoy N., Escribano M. J., Burtin P. Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA). Oncodev Biol Med. 1983;4(3):209–217. [PubMed] [Google Scholar]
- Frénoy N., Ben-Bunant M., Berruel C., Child J. A., Gendron M. C., Missett J. L., Razafimahaleo E., Burtin P. An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia. Br J Cancer. 1982 Nov;46(5):765–772. doi: 10.1038/bjc.1982.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gadler H., Bremme K., Wahren B., Hammarström S. CEA and NCA in amniotic fluid of normal and abnormal pregnancies. Cancer. 1978 Sep;42(3 Suppl):1579–1584. doi: 10.1002/1097-0142(197809)42:3+<1579::aid-cncr2820420834>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
- Harłozińska A., Potomski J., Lawinska B., Noworolska A., Richter R. High and low Fc IgG-receptor expression in human chronic granulocytic leukaemia cells. Br J Cancer. 1982 Feb;45(2):194–200. doi: 10.1038/bjc.1982.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harłozińska A., Richter R., Albert Z., Zawadzka H. Antigenic heterogeneity of human lung cancers. J Natl Cancer Inst. 1983 Mar;70(3):427–433. [PubMed] [Google Scholar]
- Ibrahim A. N., Robinson R. A., Marr L., Abdelal A. T., Nahmias A. J. Tumor-associated antigens in cervical cancer tissues and in sera from patients with cervical cancer or with head and neck cancer. J Natl Cancer Inst. 1979 Aug;63(2):319–323. [PubMed] [Google Scholar]
- Krop-Watorek A., Sedlaczek P., Lisowska E. The subunit structure of non-specific cross-reacting antigen (NCA). Mol Immunol. 1983 Jul;20(7):777–785. doi: 10.1016/0161-5890(83)90056-1. [DOI] [PubMed] [Google Scholar]
- Kula J., Harlozinska A., Richter R., Albert Z., Sward J., Gawlikowski W. Carcinoembryonic antigen in gynecologic cancers. Immunohistochemical localization and serum levels. Tumori. 1983 Feb 28;69(1):23–30. doi: 10.1177/030089168306900104. [DOI] [PubMed] [Google Scholar]
- Mach J. P., Pusztaszeri G. Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry. 1972 Oct;9(10):1031–1034. doi: 10.1016/0019-2791(72)90113-9. [DOI] [PubMed] [Google Scholar]
- Pattengale P. K., Taylor C. R., Engvall E., Ruoslahti E. Direct tissue visualization of normal cross-reacting antigen in neoplastic granulocytes. Am J Clin Pathol. 1980 Mar;73(3):351–355. doi: 10.1093/ajcp/73.3.351. [DOI] [PubMed] [Google Scholar]
- Rogers G. T. Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity. Biochim Biophys Acta. 1983 Dec 29;695(3-4):227–249. doi: 10.1016/0304-419x(83)90013-6. [DOI] [PubMed] [Google Scholar]
- Wahren B., Gahrton G., Hammarström S. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients. Cancer Res. 1980 Jun;40(6):2039–2044. [PubMed] [Google Scholar]
- Zawadzka H., Lisowska E., Harłozińska A., Albert Z., Richter R., Janusz M. Differences in the purification effect of carcinoembryonic antigen (CEA) from the three different hepatic metastases of rectum carcinoma. Neoplasma. 1979;26(2):157–167. [PubMed] [Google Scholar]
- von Kleist S., Chavanel G., Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2492–2494. doi: 10.1073/pnas.69.9.2492. [DOI] [PMC free article] [PubMed] [Google Scholar]


